We are live on ! Find out more
DFTX

Definium Therapeutics
DFTX

157 hedge funds and large institutions have $282M invested in Definium Therapeutics in 2024 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 51 increasing their positions, 29 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed

79% more call options, than puts

Call options by funds: $4.76M | Put options by funds: $2.67M

76% more repeat investments, than reductions

Existing positions increased: 51 | Existing positions reduced: 29

38% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 21

4% more funds holding

Funds holding: 151 → 157 (+6)

3.03% more ownership

Funds ownership: 57.79% → 60.82% (+3%)

6% less capital invested

Capital invested by funds: $299M → $282M (-$17.7M)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

Holders
157
Holders Change
+6
Holders Change %
+3.97%
% of All Funds
2.25%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.03%
New
29
Increased
51
Reduced
29
Closed
21
Calls
$4.76M
Puts
$2.67M
Net Calls
+$2.1M
Net Calls Change
-$8.54M

Top Buyers

Rank Fund Capital Flow
1
Blackstone Inc
Blackstone Inc
New York
+$14M
2
DCM
Driehaus Capital Management
Illinois
+$9.43M
3
TLP
Tri Locum Partners
New York
+$8.91M
4
DTC
Deep Track Capital
Connecticut
+$6.69M
5
OCA
Octagon Capital Advisors
New York
+$6.02M

Top Sellers

Rank Fund Capital Flow
1
AG
Artal Group
Luxembourg
-$7.27M
2
Two Sigma Investments
Two Sigma Investments
New York
-$2.81M
3
ABG
Ally Bridge Group
New York
-$1.23M
4
IC
Ikarian Capital
Texas
-$696K
5
AGM
Alpine Global Management
New York
-$492K
Name Holding Trade Value Shares
Change 		Change in
Stake
CPA
126
Capital Performance Advisors
California
$455 +$556 +80 New
HWM
127
HighMark Wealth Management
Minnesota
$444 – – –
SCM
128
Sterling Capital Management
North Carolina
$421 +$515 +74 New
AWM
129
Activest Wealth Management
Florida
$376 – – –
AF
130
Allworth Financial
California
$376 – – –
AF
131
Arrow Financial
New York
$376 – – –
HCM
132
Hollencrest Capital Management
California
$376 – – –
WIM
133
Westside Investment Management
California
$376 – – –
Fifth Third Bancorp
134
Fifth Third Bancorp
Ohio
$336 +$410 +59 New
TCM
135
Tradewinds Capital Management
Washington
$302 – – –
LI
136
Louisbourg Investments
New Brunswick, Canada
$296 – – –
ACM
137
Anfield Capital Management
California
$205 – – –
PMFA
138
Plante Moran Financial Advisors
Michigan
$205 – – –
TCM
139
TruNorth Capital Management
Michigan
$188 – – –
CAM
140
Chesapeake Asset Management
New York
$187 – – –
AAP
141
Arax Advisory Partners
Colorado
$160 – – –
RF
142
Robbins Farley
New Hampshire
$160 – – –
TWD
143
True Wealth Design
Ohio
$109 +$132 +19 New
CA
144
CoreCap Advisors
Michigan
$85 – – –
SIC
145
SJS Investment Consulting
Ohio
$69 – – –
CB
146
CNB Bank
Pennsylvania
$57 – – –
M
147
MOTCO
Texas
$57 – – –
BC
148
Belmont Capital
California
$34 – – –
GEA
149
Glen Eagle Advisors
New Jersey
$34 – – –
NB
150
NBT Bank
New York
$34 +$42 +6 New
4 5
6
7 8

DFTX Hedge Fund Activity: Q3 2024 in Review

157 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Definium Therapeutics (DFTX) for Q3 2024, worth a combined $282M — down 5.9% from $299M a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new DFTX positions and 21 closed out — a net gain of 8 holders — while 51 added to existing stakes and 29 trimmed.

The largest buyer was Blackstone Inc, adding an estimated $14M. The largest seller was Artal Group, exiting entirely with an estimated $7.27M sold.

  • 157 institutional investors held Definium Therapeutics (DFTX) as of Q3 2024, up from 151 in Q2 2024.
  • Funds reported $282M of Definium Therapeutics stock for Q3 2024, down 5.9% quarter-over-quarter.
  • 29 funds opened new Definium Therapeutics positions in Q3 2024 and 21 closed out, a net change of +8 holders.
  • The largest Definium Therapeutics buyer in Q3 2024 was Blackstone Inc, an estimated $14M added.
  • The largest Definium Therapeutics seller in Q3 2024 was Artal Group, an estimated $7.27M sold.

Based on aggregated 13F filings for Q3 2024.